Retinal vein occlusion: Evaluation of "classic" and "emerging" risk factors and treatment

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 4, 2010, Pages 459-464

  Turello, Marina ^a   Pasca, Samantha ^a   Daminato, Roberto ^a   Russo, Patrizia Dello ^a   Giacomello, Roberta ^a   Venturelli, Ugo ^a   Barillari, Giovanni ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Coagulation disorders; Retinal vein occlusion; Systemic risk factors; Thromboprophylaxis

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; NADROPARIN; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK FACTOR; THROMBOPHILIA; ADOLESCENT; BLINDNESS; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY;

ADOLESCENT; ADULT; AGED; BLINDNESS; BLOOD COAGULATION DISORDERS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RISK FACTORS; THROMBOPHILIA;

EID: 77955487469     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0384-5     Document Type: Article

References (35)

1. Yau J W H, Lee P, Wong TY, Best J, Jenkins A (2008) Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Inter Med J 38:904-910
2. Hayreh SS, Zimmerman MG, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117:429-441
3. Hayreh SS, Zimmermann B, McCarthy MJ, Podhajsky P (2001) Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131:61-67
4. Prisco D, Marcucci R (2002) Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophisiol Haemost Thromb 32:308-311 (Pubitemid 37490559)
5. Recchia FM, Carvalho-Recchia CA, Hassan TS (2004) Clinical course of younger patients with central retinal vein occlusion. Arch Ophthalmol 122:317-321
6. Williamson TH (1997) Central retinal vein occlusion: what's the story? Br J Ophthalmol 81:698-704
7. Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N (2005) Association of thrombophilia, hypofibrinolysis and retinal vein occlusion. Clin Appl Thromb Haemost 11:375-389
8. Kuhli C, Scharrer I, Koch F, Ohrloff C, Hattenbach L (2004) Factor XII deficiency: a thrombophilic risk factor of retinal vein occlusion. Am J Ophthalmol 137:459-464
9. Marcucci R, Giusti B, Betti I, Evangelisti L, Fedi S, Sodi A, Cappelli S, Menchini U, Abbate R, Prisco D (2003) Genetics determinants of fasting and post-methionine hiperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 110:7-12
10. Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F, Mammi C, Occhiuto A, Trapani Lombardo V (2007) Role of hyperomocysteinemia in retinal vascular occlusive disease. Clin Appl Thromb Haemost 13:104-107
11. Janssen M C H, den Heijer M, Cruysberg J R M, Wollersheim H, Bredie S J H (2005) Retinal vein occlusion: a form of venous Thrombosis or a complication of atherosclerosis? Thromb Haemost 93:1021-1026
12. Weger M, Renner W, Steinbrugger I, Cichoki L, Temmel W, Stanger O, El-Shabrawi Y, Lechner H, Schmut O, Haas A (2005) Role of thrombophilic gene polymorfism in branch retinal vein occlusion. Ophthalmology 112:1910-1915 (Pubitemid 41551918)
13. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342(10):696-701
14. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S (2004) The risk of recurrent thromboembolism in men and women. N Engl J Med 350(25):2558-2563
15. Glueck CJ, Wang P, Hutchins R, Petersen, Golnik K, 3 (2008) Ocular vascular thrombotic events: central retinal vein occlusion and central retinal artery occlusion. Clin Appl Thromb Hemost 14(3):286-294
16. Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, D Prisco (2001) Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 86:772-776
17. Cahill MT, Stinnett SS, Fekrat S (2003) Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and Thermolabile MTHFR genoype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 136:1136-1150
18. Chua B, Kifley A, Wong TY, Mitchell P (2005) Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 139:181-182
19. Coniglio M, Platania A, Di Nucci GD, Arcieri P, Modzrewska R, Mariani G (1996) Antiphospholipid-protein antibodies are not an uncommon feature in retinal vein occlusions. Thromb Res 83:183-188
20. Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P, Stroop D, Gruppo R (1999) Heritable thrombophilia and hypofibrinolysis. Arch Ophthal 1117:43-49
21. Bandello F, Viganò D'Angelo S, Parlavecchia M, Tavola A, Della Valle P, Brancato R, D'Angelo A (1994) Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 72:39-43
22. Tsantes AE, Nikolopulos GK, Bagos PG, Bonavas S, Kopterides P, Vaiopoulos G (2008) The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thromb Res 122(6):736-742
23. Gori AM, Marcucci R, Fatini C, Gensini F, Sticchi E, Sodi A, Cappelli S, Menchini U, Gensini GF, Abbate R, Prisco D (2004) Impaired fibrinolysis in retinal vein occlusion: a role of genetics determinants of PAI-1 levels. Thromb Haemost 92:54-60
24. Ay C, Bencur P, Vormittag R, Sailer T, Jungbauer C, Vukovich T, Mannhalter C, Pabinger I (2007) The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Thromb Haemost 98(4):777-782
25. Larsson J, Olafsdottir E, Bauer B (1996) Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 80:200-202
26. Scat Y, Morin Y, Morel C et al (1995) Retinal vein occlusion and resistance to activated protein C. J Fr Ophthalmol 18:758-762
27. Williamson TH, Rumley A, Lowe GD (1996) Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: a population-controlled study. Br J Ophtalmol 80:203-208
28. Graham SL, Goldbberg I, Murray B, Beaumont P, Chong BH (1996) Activated protein C resistance: low incidence in glaucomatous disk hemorrage and central retinal vein occlusion. Aust N Z J Ophthalmol 24:199-205
29. Gottlieb JL, Blice J P, Mestichelli B, Konkle BA, Benson WE (1998) Activated protein C resistance, Factor V Leiden and central retinal vein occlusion in young adults. Arch Ophthalmol 116:577-579
30. Marcucci R, Bertini L, Alessandriello Liotta A, Rogolino A, Antonucci E, Ilari I, Pepe G, Prisco D (2000) Activated protein C resistance is a risk factor for central retinal vein occlusion. Ann Ital Med Int 15:195-198
31. Albisinni R, Coppola A, Loffredo M, Cerbone AM, Di Minno G, Greco GM (1998) Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost 80:702-703
32. Prisco D, Marcucci R, Bertini L, Gori AM (2002) Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Int Med 13:163-169
33. Prisco D, Bertini L, Marcucci R, Poli D (2000) Le occlusioni venose retiniche: malattie internistiche? Ann Ital Med Int 15:75-84
34. Leoncini G, Bruzzese D, Signorello MG, Armani U, Piana A, Ghiglione D, Camicione P (2007) Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost 97:218-277
35. Meschengieser SS (2005) Retinal vein occlusion: a venous complication in an "arterial" patient? Thromb Haemost 93:1013